TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.

Miguel Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.